← Back to Search

Tele-Navigation for Lung Cancer Screening

N/A

Waitlist Available

Led By Mayuko Ito Fukunaga, MD

Research Sponsored by University of Massachusetts, Worcester

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

English speaker

Has undergone LCS at UMMH

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 180 days

Awards & highlights

Study Summary

This trial seeks to improve follow-up of Lung Cancer Screening (LCS) through Tele-Navigation, to ultimately reduce mortality & optimize cost-effectiveness.

Who is the study for?

This trial is for English-speaking individuals who are eligible for and overdue a low-dose CT scan (LDCT) as part of lung cancer screening follow-up. Participants must have had their initial screening at UMMH and possess the technology to complete study activities, such as video calls. Those with a previous or active cancer diagnosis, nursing home residents, or pregnant individuals cannot join.Check my eligibility

What is being tested?

The Tele-Navi LCS intervention uses telehealth to improve adherence to follow-up lung cancer screenings. The study will create this program with patient input and test its feasibility in primary care by tracking if participants complete it and their subsequent LDCT within 180 days.See study design

What are the potential side effects?

Since Tele-Navi LCS is a non-medical intervention involving telehealth navigation support, there are no direct medical side effects associated with drugs or procedures. However, participants may experience issues related to the use of technology.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I speak English.

Select...

I have had a lung cancer screening at UMMH.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 180 days

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~180 days

This trial's timeline: 3 weeks for screening, Varies for treatment, and 180 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Completion of Tele-Navi LCS

Secondary outcome measures

Completion of Follow-up LCS

Trial Design

1Treatment groups

Experimental Treatment

Group I: Tele-Navi LCSExperimental Treatment1 Intervention

Tele-Navi of LCS includes: telehealth coaching from a Tele-Navigator for patients undergoing LCS to access a patient portal and a video-call system.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Meyers Primary Care InstituteUNKNOWN

University of Massachusetts, WorcesterLead Sponsor

343 Previous Clinical Trials

986,588 Total Patients Enrolled

Wake Forest University Health SciencesOTHER

1,243 Previous Clinical Trials

1,004,708 Total Patients Enrolled

Media Library

Tele-Navi LCS Clinical Trial Eligibility Overview. Trial Name: NCT05021133 — N/A

Lung Cancer Research Study Groups: Tele-Navi LCS

Lung Cancer Clinical Trial 2023: Tele-Navi LCS Highlights & Side Effects. Trial Name: NCT05021133 — N/A

Tele-Navi LCS 2023 Treatment Timeline for Medical Study. Trial Name: NCT05021133 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the trial open to participants of all ages, or are there age restrictions?

"This clinical trial is only open to those aged 50-77. Subsequently, there are 43 studies for minors below the age of 18 and 1645 trials available for seniors over 65 years old."

Answered by AI

Is there still availability for participants in this research project?

"Clinicialtrials.gov confirms that this clinical trial is not currently recruiting patients, having been initially posted on June 5th of 2023 and most recently edited one day later. However, 1654 other studies are actively searching for volunteers at present."

Answered by AI

What are the requirements for individuals to participate in this clinical trial?

"For consideration in this medical trial, patients must have lung cancer and be between the ages of 50-77. The study seeks to enroll 20 participants in total."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Tele-Navigation of Lung Cancer Screening (Tele-Navi LCS)

Mayuko Ito Fukunaga 2023. "Tele-Navigation of Lung Cancer Screening (Tele-Navi LCS)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05021133.